Novavax Says FDA Approval Back on Track for Its COVID Vaccine

Novavax Says FDA Approval Back on Track for Its COVID Vaccine

Credits: Canva

Text

Updated Apr 24, 2025 | 10:00 AM IST

SummaryNovavax’s vaccine, which is the only protein-based COVID-19 vaccine, is awaiting for its full approval. Once approved, it could remain on the market even after the official end of the COVID-19 public health emergency.

End of Article